Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

roche.com

Roche Media News

Get the latest updates from Roche Media News directly as they happen.

Follow now 323 followers

Latest posts

Last updated about 3 hours ago

Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH

about 3 hours ago

89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe...

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

19 days ago

Phase III trial informed by comprehensive KARDIA data set generated through three...

Roche’s US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USA

24 days ago

The $700 million project is part of Roche’s $50 billion investment in...

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)

about 2 months ago

Susvimo is the only continuous delivery treatment to provide reliable, long-term vision...

Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC

about 2 months ago

Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust...

Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU

about 2 months ago

EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for...

[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum with 7% growth (CER) in the first half of 2025

about 2 months ago

Basel, 24 July 2025 Group sales grew by 7%1 at constant exchange...

Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer’s disease

about 2 months ago

Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test...

European Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation

about 2 months ago

Approval based on INAVO120 data showing the Itovebi™ (inavolisib)-based regimen more than...

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

about 2 months ago

Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will...